Related Content
Search Google Scholar for:
|
|
Science 1 November 1985: Vol. 230. no. 4725, pp. 561 - 563 DOI: 10.1126/science.2931802
|
|
Articles
Science, Vol 230, Issue 4725, 561-563
Copyright © 1985 by American Association for the Advancement of Science
Selective sparing of a class of striatal neurons in Huntington's disease
RJ Ferrante,
NW Kowall,
MF Beal,
EP Richardson Jr,
ED Bird,
and
JB Martin
A distinct subpopulation of striatal aspiny neurons, containing the enzyme nicotinamide adenine dinucleotide phosphate diaphorase, is preserved in the caudate nucleus in Huntington's disease. Biochemical assays confirmed a significant increase in the activity of this enzyme in both the caudate nucleus and putamen in postmortem brain tissue from patients with this disease. The resistance of these neurons suggests that the gene defect in Huntington's disease may be modifiable by the local biochemical environment. This finding may provide insight into the nature of the genetically programmed cell death that is a characteristic of the disease.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- The lysosome and neurodegenerative diseases.
- L. Zhang, R. Sheng, and Z. Qin (2009)
Acta Biochim Biophys Sin
41, 437-445
| Abstract »
| Full Text »
| PDF »
- Neuroprotective Effects of Synaptic Modulation in Huntington's Disease R6/2 Mice.
- E. C. Stack, A. Dedeoglu, K. M. Smith, K. Cormier, J. K. Kubilus, M. Bogdanov, W. R. Matson, L. Yang, B. G. Jenkins, R. Luthi-Carter, et al. (2007)
J. Neurosci.
27, 12908-12915
| Abstract »
| Full Text »
| PDF »
- Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin.
- M. Cyr, T. D. Sotnikova, R. R. Gainetdinov, and M. G. Caron (2006)
FASEB J
20, 2541-2543
| Abstract »
| Full Text »
| PDF »
- FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease.
- K. Jin, M. LaFevre-Bernt, Y. Sun, S. Chen, J. Gafni, D. Crippen, A. Logvinova, C. A. Ross, D. A. Greenberg, and L. M. Ellerby (2005)
PNAS
102, 18189-18194
| Abstract »
| Full Text »
| PDF »
- Neuropeptide Y Protects against Methamphetamine-Induced Neuronal Apoptosis in the Mouse Striatum.
- N. Thiriet, X. Deng, M. Solinas, B. Ladenheim, W. Curtis, S. R. Goldberg, R. D. Palmiter, and J. L. Cadet (2005)
J. Neurosci.
25, 5273-5279
| Abstract »
| Full Text »
| PDF »
- Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1.
- B. Zucker, R. Luthi-Carter, J. A. Kama, A. W. Dunah, E. A. Stern, J. H. Fox, D. G. Standaert, A. B. Young, and S. J. Augood (2005)
Hum. Mol. Genet.
14, 179-189
| Abstract »
| Full Text »
| PDF »
- Huntington and its Role in Neuronal Degeneration.
- S.-H. Li and X.-J. Li (2004)
Neuroscientist
10, 467-475
| Abstract »
| PDF »
- Diagnosis of Huntington Disease.
- R. L. Margolis and C. A. Ross (2003)
Clin. Chem.
49, 1726-1732
| Abstract »
| Full Text »
| PDF »
- Endogenous Dopamine Amplifies Ischemic Long-Term Potentiation via D1 Receptors.
- E. Saulle, D. Centonze, A. B. Martin, R. Moratalla, G. Bernardi, and P. Calabresi (2002)
Stroke
33, 2978-2984
| Abstract »
| Full Text »
| PDF »
- Characterization of a Brain-enriched Chaperone, MRJ, That Inhibits Huntingtin Aggregation and Toxicity Independently.
- J.-Z. Chuang, H. Zhou, M. Zhu, S.-H. Li, X.-J. Li, and C.-H. Sung (2002)
J. Biol. Chem.
277, 19831-19838
| Abstract »
| Full Text »
| PDF »
- Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability.
- P. Calabresi, E. Saulle, D. Centonze, A. Pisani, G. A. Marfia, and G. Bernardi (2002)
Brain
125, 844-860
| Abstract »
| Full Text »
| PDF »
- Huntingtin Aggregate-Associated Axonal Degeneration is an Early Pathological Event in Huntington's Disease Mice.
- H. Li, S.-H. Li, Z.-X. Yu, P. Shelbourne, and X.-J. Li (2001)
J. Neurosci.
21, 8473-8481
| Abstract »
| Full Text »
| PDF »
- Activation of Metabotropic Glutamate Receptor Subtype 1/Protein Kinase C/Mitogen-Activated Protein Kinase Pathway Is Required for Postischemic Long-Term Potentiation in the Striatum.
- P. Calabresi, E. Saulle, G. A. Marfia, D. Centonze, R. Mulloy, B. Picconi, R. A. Hipskind, F. Conquet, and G. Bernardi (2001)
Mol. Pharmacol.
60, 808-815
| Abstract »
| Full Text »
| PDF »
- Expression of Brain-Derived Neurotrophic Factor in Cortical Neurons Is Regulated by Striatal Target Area.
- J. M. Canals, N. Checa, S. Marco, P. Akerud, A. Michels, E. Perez-Navarro, E. Tolosa, E. Arenas, and J. Alberch (2001)
J. Neurosci.
21, 117-124
| Abstract »
| Full Text »
| PDF »
- Cellular factors controlling neuronal vulnerability in the brain: A lesson from the striatum.
- P. Calabresi, D. Centonze, and G. Bernardi (2000)
Neurology
55, 1249-1255
| Abstract »
| Full Text »
| PDF »
- Intraneuronal Aggregate Formation and Cell Death after Viral Expression of Expanded Polyglutamine Tracts in the Adult Rat Brain.
- M.-C. Senut, S. T. Suhr, B. Kaspar, and F. H. Gage (2000)
J. Neurosci.
20, 219-229
| Abstract »
| Full Text »
| PDF »
- Cellular Defects and Altered Gene Expression in PC12 Cells Stably Expressing Mutant Huntingtin.
- S.-H. Li, A. L. Cheng, H. Li, and X.-J. Li (1999)
J. Neurosci.
19, 5159-5172
| Abstract »
| Full Text »
| PDF »
- Electrophysiological Recordings and Calcium Measurements in Striatal Large Aspiny Interneurons in Response to Combined O2/Glucose Deprivation.
- A. Pisani, P. Calabresi, D. Centonze, G. A. Marfia, and G. Bernardi (1999)
J Neurophysiol
81, 2508-2516
| Abstract »
| Full Text »
| PDF »
- Cellular Localization of Huntingtin in Striatal and Cortical Neurons in Rats: Lack of Correlation with Neuronal Vulnerability in Huntington's Disease.
- F. R. Fusco, Q. Chen, W. J. Lamoreaux, G. Figueredo-Cardenas, Y. Jiao, J. A. Coffman, D. J. Surmeier, M. G. Honig, L. R. Carlock, and A. Reiner (1999)
J. Neurosci.
19, 1189-1202
| Abstract »
| Full Text »
| PDF »
- Targeted Expression of a Toxin Gene to D1 Dopamine Receptor Neurons by Cre-Mediated Site-Specific Recombination.
- J. Drago, P. Padungchaichot, J. Y. F. Wong, A. J. Lawrence, J. F. McManus, S. H. Sumarsono, A. L. Natoli, M. Lakso, N. Wreford, H. Westphal, et al. (1998)
J. Neurosci.
18, 9845-9857
| Abstract »
| Full Text »
| PDF »
- A Human HAP1 Homologue. CLONING, EXPRESSION, AND INTERACTION WITH HUNTINGTIN.
- S.-H. Li, S. H. Hosseini, C.-A. Gutekunst, S. M. Hersch, R. J. Ferrante, and X.-J. Li (1998)
J. Biol. Chem.
273, 19220-19227
| Abstract »
| Full Text »
| PDF »
- Manganese Superoxide Dismutase Protects nNOS Neurons from NMDA and Nitric Oxide-Mediated Neurotoxicity.
- M. Gonzalez-Zulueta, L. M. Ensz, G. Mukhina, R. M. Lebovitz, R. M. Zwacka, J. F. Engelhardt, L. W. Oberley, V. L. Dawson, and T. M. Dawson (1998)
J. Neurosci.
18, 2040-2055
| Abstract »
| Full Text »
| PDF »
- NMDAR1 Glutamate Receptor Subunit Isoforms in Neostriatal, Neocortical, and Hippocampal Nitric Oxide Synthase Neurons.
- S. W. Weiss, D. S. Albers, M. J. Iadarola, T. M. Dawson, V. L. Dawson, and D. G. Standaert (1998)
J. Neurosci.
18, 1725-1734
| Abstract »
| Full Text »
| PDF »
- Heterogeneous Topographic and Cellular Distribution of Huntingtin Expression in the Normal Human Neostriatum.
- R. J. Ferrante, C.-A. Gutekunst, F. Persichetti, S. M. McNeil, N. W. Kowall, J. F. Gusella, M. E. MacDonald, M. F. Beal, and S. M. Hersch (1997)
J. Neurosci.
17, 3052-3063
| Abstract »
| Full Text »
| PDF »
- Expression of Normal and Mutant Huntingtin in the Developing Brain.
- P. G. Bhide, M. Day, E. Sapp, C. Schwarz, A. Sheth, J. Kim, A. B. Young, J. Penney, J. Golden, N. Aronin, et al. (1996)
J. Neurosci.
16, 5523-5535
| Abstract »
| Full Text »
| PDF »
- Effect of Scrapie Infection on the Activity of Neuronal Nitric-oxide Synthase in Brain and Neuroblastoma Cells.
- H. Ovadia, H. Rosenmann, E. Shezen, M. Halimi, I. Ofran, and R. Gabizon (1996)
J. Biol. Chem.
271, 16856-16861
| Abstract »
| Full Text »
| PDF »
- Maldistribution of Interstitial Neurons in Prefrontal White Matter of the Brains of Schizophrenic Patients.
- S. Akbarian, J. J. Kim, S. G. Pothin, W. P. Hetrick, W. E. Bunney Jr, and E. G. Jones (1996)
Arch Gen Psychiatry
53, 425-436
| Abstract »
| PDF »
- Nitric Oxide, Cell Multiplication, and Cell Survival.
- N. Peunova, B. Kuzin, I. Roberts, C. O'Kane, and G. Enikolopov (1996)
Cold Spring Harb Symp Quant Biol
61, 417-426
| Abstract »
| PDF »
- Altered Distribution of Nicotinamide-Adenine Dinucleotide Phosphate--Diaphorase Cells in Frontal Lobe of Schizophrenics Implies Disturbances of Cortical Development.
- S. Akbarian, W. E. Bunney Jr, S. G. Potkin, S. B. Wigal, J. O. Hagman, C. A. Sandman, and E. G. Jones (1993)
Arch Gen Psychiatry
50, 169-177
| Abstract »
| PDF »
- Distorted Distribution of Nicotinamide-Adenine Dinucleotide Phosphate--Diaphorase Neurons in Temporal Lobe of Schizophrenics Implies Anomalous Cortical Development.
- S. Akbarian, A. Vinuela, J. J. Kim, S. G. Potkin, W. E. Bunney Jr, and E. G. Jones (1993)
Arch Gen Psychiatry
50, 178-187
| Abstract »
| PDF »
- Nitric oxide: first in a new class of neurotransmitters.
- S. Snyder (1992)
Science
257, 494-496
| PDF »
- NMDA receptor losses in putamen from patients with Huntington's disease.
- A. Young, J. Greenamyre, Z Hollingsworth, R Albin, C D'Amato, I Shoulson, and J. Penney (1988)
Science
241, 981-983
| Abstract »
| PDF »
- Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons.
- S Peters, J Koh, and D. Choi (1987)
Science
236, 589-593
| Abstract »
| PDF »
- Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity.
- J. Koh, S Peters, and D. Choi (1986)
Science
234, 73-76
| Abstract »
| PDF »
- Molecular Genetics of Huntington's Disease.
- J.F. Gusella, T.C. Gilliam, R.E. Tanzi, M.E. MacDonald, S.V. Cheng, M. Wallace, J. Haines, P.M. Conneally, and N.S. Wexler (1986)
Cold Spring Harb Symp Quant Biol
51, 359-364
| Abstract »
| PDF »
- Activation of MLK2-mediated Signaling Cascades by Polyglutamine-expanded Huntingtin.
- Y. F. Liu, D. Dorow, and J. Marshall (2000)
J. Biol. Chem.
275, 19035-19040
| Abstract »
| Full Text »
| PDF »
|
|